发明名称 TREATMENT PREDICTION INVOLVING HMGCR PROTEIN
摘要 <p>The present invention provides a method for determining whether a mammalian subject having a breast cancer is likely to benefit from an endocrine treatment, comprising the steps of: providing a sample earlier obtained from said subject; evaluating the amount of HMGCR protein present in at least part of said sample, and determining a sample value corresponding to said amount; comparing the sample value obtained in step b) with a reference value; and, if said sample value is higher than said reference value, concluding that the subject is likely to benefit from an endocrine treatment. Further, a corresponding method of treatment is provided as well as further methods uses and means which may be employed in connection with breast cancer treatment or treatment prediction.</p>
申请公布号 WO2009139681(A8) 申请公布日期 2013.11.21
申请号 WO2009SE00066 申请日期 2009.01.30
申请人 ATLAS ANTIBODIES AB;UHLEN, MATHIAS;PONTEN, FREDRIK;JIRSTROEM, KARIN 发明人 UHLEN, MATHIAS;PONTEN, FREDRIK;JIRSTROEM, KARIN
分类号 C12Q1/26;G01N33/574 主分类号 C12Q1/26
代理机构 代理人
主权项
地址
您可能感兴趣的专利